[{"Assets_0_Q3_USD":385587198.0,"CommonStockSharesOutstanding_0_Q3_shares":54713831.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-89007577.0,"NetIncomeLoss_1_Q3_USD":-41522914.0,"NetIncomeLoss_3_Q3_USD":-114379375.0,"StockholdersEquity_0_Q3_USD":353625396.0,"Ticker":"ITCI","CIK":"1567514","name":"INTRA-CELLULAR THERAPIES, INC.","OfficialName":"Intra-Cellular Therapies Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5718578003.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]